Literature DB >> 27013197

NFAT1 Directly Regulates IL8 and MMP3 to Promote Melanoma Tumor Growth and Metastasis.

Einav Shoshan1, Russell R Braeuer1, Takafumi Kamiya1, Aaron K Mobley1, Li Huang1, Mayra E Vasquez1, Guermarie Velazquez-Torres1, Nitin Chakravarti2, Cristina Ivan3, Victor Prieto2, Gabriel J Villares4, Menashe Bar-Eli5.   

Abstract

Nuclear factor of activated T cell (NFAT1, NFATC2) is a transcription factor that binds and positively regulates IL2 expression during T-cell activation. NFAT1 has important roles in both innate and adaptive immune responses, but its involvement in cancer is not completely understood. We previously demonstrated that NFAT1 contributes to melanoma growth and metastasis by regulating the autotaxin gene (Enpp2). Here, we report a strong correlation between NFAT1 expression and metastatic potential in melanoma cell lines and tumor specimens. To elucidate the mechanisms underlying NFAT1 overexpression during melanoma progression, we conducted a microarray on a highly metastatic melanoma cell line in which NFAT1 expression was stably silenced. We identified and validated two downstream targets of NFAT1, IL8, and MMP3. Accordingly, NFAT1 depletion in metastatic melanoma cell lines was associated with reduced IL8 and MMP3 expression, whereas NFAT1 overexpression in a weakly metastatic cell line induced expression of these targets. Restoration of NFAT1 expression recovered IL8 and MMP3 expression levels back to baseline, indicating that both are direct targets of NFAT1. Moreover, in vivo studies demonstrated that NFAT1 and MMP3 promoted melanoma tumor growth and lung metastasis. Collectively, our findings assign a new role for NFAT1 in melanoma progression, underscoring the multifaceted functions that immunomodulatory factors may acquire in an unpredictable tumor microenvironment. Cancer Res; 76(11); 3145-55. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27013197      PMCID: PMC4891299          DOI: 10.1158/0008-5472.CAN-15-2511

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

Review 1.  Transcription factors of the NFAT family: regulation and function.

Authors:  A Rao; C Luo; P G Hogan
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

2.  Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression.

Authors:  Conan Kinsey; Vijaya Balakrishnan; Michael R O'Dell; Jing Li Huang; Laurel Newman; Christa L Whitney-Miller; Aram F Hezel; Hartmut Land
Journal:  Cell Rep       Date:  2014-05-01       Impact factor: 9.423

3.  Identification of a putative regulator of early T cell activation genes.

Authors:  J P Shaw; P J Utz; D B Durand; J J Toole; E A Emmel; G R Crabtree
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728

4.  Characterization of antigen receptor response elements within the interleukin-2 enhancer.

Authors:  D B Durand; J P Shaw; M R Bush; R E Replogle; R Belagaje; G R Crabtree
Journal:  Mol Cell Biol       Date:  1988-04       Impact factor: 4.272

5.  Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB.

Authors:  Badar M Mian; Colin P N Dinney; Carlos E Bermejo; Paul Sweeney; Carmen Tellez; X D Yang; Jean M Gudas; David J McConkey; Menashe Bar-Eli
Journal:  Clin Cancer Res       Date:  2003-08-01       Impact factor: 12.531

6.  Apoptosis suppression by candidate oncogene PLAC8 is reversed in other cell types.

Authors:  Mirna Mourtada-Maarabouni; David Watson; Mamoona Munir; Farzin Farzaneh; Gwyn T Williams
Journal:  Curr Cancer Drug Targets       Date:  2013-01       Impact factor: 3.428

7.  Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites.

Authors:  L Li; J E Price; D Fan; R D Zhang; C D Bucana; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1989-09-20       Impact factor: 13.506

8.  NFAT1 supports tumor-induced anergy of CD4(+) T cells.

Authors:  Brian T Abe; Daniel S Shin; Enric Mocholi; Fernando Macian
Journal:  Cancer Res       Date:  2012-08-03       Impact factor: 12.701

9.  Excess PLAC8 promotes an unconventional ERK2-dependent EMT in colon cancer.

Authors:  Cunxi Li; Haiting Ma; Yang Wang; Zheng Cao; Ramona Graves-Deal; Anne E Powell; Alina Starchenko; Gregory D Ayers; Mary Kay Washington; Vidya Kamath; Keyur Desai; Michael J Gerdes; Lila Solnica-Krezel; Robert J Coffey
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

10.  Uncovering the mechanisms that regulate tumor-induced T-cell anergy.

Authors:  Brian T Abe; Fernando Macian
Journal:  Oncoimmunology       Date:  2013-02-01       Impact factor: 8.110

View more
  39 in total

1.  In situ self-assembling Au-DNA complexes for targeted cancer bioimaging and inhibition.

Authors:  Maonan Wang; Yun Chen; Weijuan Cai; Huan Feng; Tianyu Du; Weiwei Liu; Hui Jiang; Alberto Pasquarelli; Yossi Weizmann; Xuemei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-16       Impact factor: 11.205

2.  Role of hair follicles in the pathogenesis of arsenical-induced cutaneous damage.

Authors:  Ritesh K Srivastava; Yong Wang; Jasim Khan; Suhail Muzaffar; Madison B Lee; Zhiping Weng; Claire Croutch; Anupam Agarwal; Jessy Deshane; Mohammad Athar
Journal:  Ann N Y Acad Sci       Date:  2022-06-09       Impact factor: 6.499

3.  [Metformin and lipopolysaccharide regulate transcription of NFATc2 gene via the transcription factor RUNX2].

Authors:  X Xue; Z Li; M Zhao
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-03-20

Review 4.  For robust big data analyses: a collection of 150 important pro-metastatic genes.

Authors:  Yan Mei; Jun-Ping Yang; Chao-Nan Qian
Journal:  Chin J Cancer       Date:  2017-01-21

5.  miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1.

Authors:  Zheng Fang; Shuai Yin; Ruochuan Sun; Shangxin Zhang; Min Fu; Youliang Wu; Tao Zhang; Junaid Khaliq; Yongxiang Li
Journal:  Mol Cancer       Date:  2017-08-17       Impact factor: 27.401

6.  LncRNA GAS5 is a critical regulator of metastasis phenotype of melanoma cells and inhibits tumor growth in vivo.

Authors:  Long Chen; Huixin Yang; Yanbin Xiao; Xiaoxia Tang; Yuqian Li; Qiaoqiao Han; Junping Fu; Yuye Yang; Yuechun Zhu
Journal:  Onco Targets Ther       Date:  2016-07-04       Impact factor: 4.147

Review 7.  Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation.

Authors:  Matthew G K Benesch; Iain T K MacIntyre; Todd P W McMullen; David N Brindley
Journal:  Cancers (Basel)       Date:  2018-03-15       Impact factor: 6.639

8.  MiR-519d suppresses breast cancer tumorigenesis and metastasis via targeting MMP3.

Authors:  Chengling Chu; Xin Liu; Xue Bai; Tong Zhao; Mengxue Wang; Ranchen Xu; Mingqi Li; Yingying Hu; Weihua Li; Lida Yang; Youyou Qin; Meng Yang; Chaoqi Yan; Yong Zhang
Journal:  Int J Biol Sci       Date:  2018-02-09       Impact factor: 6.580

9.  17-Aminogeldanamycin Inhibits Constitutive Nuclear Factor-Kappa B (NF-κB) Activity in Patient-Derived Melanoma Cell Lines.

Authors:  Mariusz L Hartman; Magdalena Rogut; Aleksandra Mielczarek-Lewandowska; Michal Wozniak; Malgorzata Czyz
Journal:  Int J Mol Sci       Date:  2020-05-26       Impact factor: 5.923

10.  Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages.

Authors:  Marta Di Martile; Valentina Farini; Francesca Maria Consonni; Daniela Trisciuoglio; Marianna Desideri; Elisabetta Valentini; Simona D'Aguanno; Maria Grazia Tupone; Simonetta Buglioni; Cristiana Ercolani; Enzo Gallo; Bruno Amadio; Irene Terrenato; Maria Laura Foddai; Antonio Sica; Donatella Del Bufalo
Journal:  J Immunother Cancer       Date:  2020-04       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.